Sun Pharma share price declines as it revises bid to buy balance Taro stake
| TARODelisted Stock | USD 42.97 0.00 0.00% |
About 56% of Taro Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Taro Pharmaceutical Industries suggests that many traders are alarmed regarding Taro Pharmaceutical's prospects. Taro Pharmaceutical's investing sentiment overview a quick insight into current market opportunities from investing in Taro Pharmaceutical Industries. Many technical investors use Taro Pharmaceutical stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Taro |
Stock market Today- Sun Pharma increased its bid to purchase the outstanding shares of its US subsidiary, Taro Pharma from 38 per share to 43 per share in cash. This move is part of Sun Pharmas strategic plan, announced in May, to acquire 100 percent ownership of Taro.
Read at livemint.com
 |
Taro Pharmaceutical Fundamental Analysis
We analyze Taro Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taro Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taro Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Taro Pharmaceutical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Taro Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taro Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Taro Pharmaceutical could also be used in its relative valuation, which is a method of valuing Taro Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Taro Pharmaceutical Related Equities
| RDHL | Redhill Biopharma | 1.41 | ||||
| COLL | Collegium Pharmaceutical | 1.30 | ||||
| SUPN | Supernus Pharmaceuticals | 0.11 | ||||
| LFCR | Lifecore Biomedical | 0.27 | ||||
| AMPH | Amphastar | 0.94 | ||||
| RDY | Dr Reddys | 1.26 | ||||
| ANIP | ANI Pharmaceuticals | 1.33 | ||||
| PAHC | Phibro Animal | 1.70 | ||||
| PBH | Prestige Brand | 1.74 | ||||
| ORGO | Organogenesis Holdings | 1.98 | ||||
| EVO | Evotec SE | 2.66 | ||||
| PCRX | Pacira BioSciences, | 3.67 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Taro Stock
If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |